Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Non-damaging Retinal Laser Therapy Using PASCAL Laser With Endpoint Management Software for Macular Diseases

NCT01975103 is registered in ClinicalTrials.gov with Federal University of Rio Grande do Sul as lead sponsor.

NCT NCT01975103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01975103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Non-damaging Retinal Laser Therapy Using PASCAL Laser With Endpoint Management Software for Macular Diseases
Lead sponsor
Federal University of Rio Grande do Sul
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2013
Completion date
April 30, 2020
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

branch retinal vein occlusion, chronic central serous retinopathy, diabetic macular edema, macular telangiectasia